Immunohistochemical analysis of 14‐3‐3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pathology international (Print)

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1440-1827.2004.01668.xPMID 15260850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Problems in Breast Pathology

  2006cited by this paper
• TP53 alterations in atypical ductal hyperplasia and ductal carcinomain situ of the breast

  2005cited by this paper
• Basal clear cells of the normal human breast

  2004cited by this paper
• Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: assessment of ACD as a precancerous lesion.

  2004cited by this paper
• Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept

  2003cited by this paper
• Gene expression profiles of human breast cancer progression

  2003cited by this paper
• A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers

  2003cited by this paper
• 14-3-3 proteins : a highly conserved widespread family of eukaryotic proteins

  2003cited by this paper
• Immunohistochemical demonstration of 14‐3‐3 sigma protein in normal human tissues and lung cancers, and the preponderance of its strong expression in epithelial cells of squamous cell lineage

  2003cited by this paper
• Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ

  2002cited by this paper
• Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

  2002cited by this paper
• Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth

  2002cited by this paper
• Quantitative assessment of promoter hypermethylation during breast cancer development.

  2002cited by this paper
• Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.

  2002cited by this paper
• Molecular and Biologic Markers of Premalignant Lesions of Human Breast

  2002cited by this paper
• Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.

  2002cited by this paper
• Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer

  2001cited by this paper
• Morphological observations regarding the origins of atypical cystic lobules (low-grade clinging carcinoma of flat type)

  2001cited by this paper
• Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

  2001cited by this paper
• Progesterone Receptor A and B Isoforms in the Human Breast and Its Disorders

  2001cited by this paper
• The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer

  2001cited by this paper
• Analysis of estrogen‐responsive finger protein expression in benign and malignant human breast

  2001cited by this paper
• BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells.

  2001cited by this paper
• Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.

  2001cited by this paper
• BRCA1 Is a Selective Co-activator of 14-3-3ς Gene Transcription in Mouse Embryonic Stem Cells* 210

  2001cited by this paper
• Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells

  2001cited by this paper
• Flat type of intraductal carcinoma

  2001cited by this paper
• Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression*

  2000cited by this paper
• BRCA1 Expression Status in Relation to DNA Methylation of the BRCA1 Promoter Region in Sporadic Breast Cancers

  2000cited by this paper
• Retinoic Acid Receptor and Retinoid × Receptor in Ductal Carcinoma in situ and Intraductal Proliferative Lesions of the Human Breast

  2000cited by this paper
• High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

  2000cited by this paper
• P53 expression in patients with malignant and benign breast diseases.

  2000cited by this paper
• Genetic abnormalities in mammary ductal intraepithelial neoplasia‐flat type (“clinging ductal carcinoma in situ”)

  2000cited by this paper
• Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: Assessment of ACD as a precancerous lesion

  2000cited by this paper
• 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.

  1999cited by this paper
• Maintenance of G2 arrest in the Xenopus oocyte: a role for 14‐3‐3‐mediated inhibition of Cdc25 nuclear import

  1999cited by this paper
• Atypical cystic lobules: an early stage in the formation of low-grade ductal carcinoma in situ

  1999cited by this paper
• Oestrogen receptor expression in the normal and pre‐cancerous breast

  1999cited by this paper
• 14-3-3σ is required to prevent mitotic catastrophe after DNA damage

  1999cited by this paper
• p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

  1998cited by this paper
• 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

  1997cited by this paper
• 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression

  1997cited by this paper
• Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation.

  1997cited by this paper
• Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.

  1997cited by this paper
• Loss of an Estrogen Receptor Isoform (ERαΔ3) in Breast Cancer and the Consequences of Its Reexpression: Interference with Estrogen-Stimulated Properties of Malignant Transformation

  1997cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

  1994cited by this paper
• 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins.

  1992cited by this paper
• Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia.

  1992cited by this paper
• Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells.

  1992cited by this paper
• Basal cell-specific and hyperproliferation-related keratins in human breast cancer.

  1991cited by this paper
• Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

  1990cited by this paper
• Antibody markers of basal cells in complex epithelia.

  1990cited by this paper
• Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• The general rules for clinical and pathological recording of breast cancer

  1989cited by this paper
• The fine structure of ducts and subareolar ducts in the resting gland of the female breast

  1977cited by this paper

• Estrogen Receptor α/14-3-3 molecular glues as alternative treatment strategy for endocrine resistant breast cancer

  2024cites this paper
• The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases.

  2023cites this paper
• Interactions between 14-3-3 Proteins and Actin Cytoskeleton and Its Regulation by microRNAs and Long Non-Coding RNAs in Cancer

  2022cites this paper
• VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem-like epithelial cells

  2020cites this paper
• Altered expression of microRNA‐365 is related to the occurrence and development of non‐small‐cell lung cancer by inhibiting TRIM25 expression

  2019cites this paper
• TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer

  2018cites this paper
• Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling

  2017cites this paper
• TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling

  2016cites this paper
• The role of 14-3-3 proteins in gynecological tumors.

  2015cites this paper
• The Role and Regulatory Mechanism of 14-3-3 Sigma in Human Breast Cancer

  2014cites this paper
• Differential subcellular and extracellular localisations of proteins required for insulin-like growth factor- and extracellular matrix-induced signalling events in breast cancer progression

  2014cites this paper
• Downregulation of 14-3-3σ Correlates with Multistage Carcinogenesis and Poor Prognosis of Esophageal Squamous Cell Carcinoma

  2014cites this paper
• Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.

  2013cites this paper
• Intraepithelial Neoplasia of Breast

  2012cites this paper
• 14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers

  2012cites this paper
• The 14-3-3σ tumor suppressor has multiple functions in ErbB2-induced breast cancer.

  2012cites this paper
• 5 Intraepithelial Neoplasia of Breast

  2012cites this paper
• Expression of 14-3-3 σ protein in normal and neoplastic canine mammary gland.

  2011cites this paper
• Lack of RUNX3 inactivation in columnar cell lesions of breast

  2010cites this paper
• Immunohistochemical localisation of 14-3-3 sigma protein in normal canine tissues.

  2010cites this paper
• Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.

  2010cites this paper
• The role of estrogen-responsive finger protein (Efp) and 14-3-3 sigma ( ) σ in breast carcinogenesis and their prognostic implication

  2009cites this paper
• Flat epithelial atypia of the breast.

  2009cites this paper
• Higher expression levels of 14-3-3σ in ductal carcinoma in situ of the breast predict poorer outcome

  2009cites this paper
• Columnar cell lesions of the breast: an update and significance on core biopsy

  2009cites this paper
• Clinical significance of 14-3-3 zeta in human esophageal cancer.

  2008cites this paper
• Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?

  2008cites this paper
• Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics.

  2008cites this paper
• Clinical Significance of 14-3-3 Zeta in Human Esophageal Cancer

  2008cites this paper
• Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma

  2007cites this paper
• Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers

  2007cites this paper
• Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

  2007cites this paper
• Epigenetic silencing of 14-3-3sigma in cancer.

  2006cites this paper
• Biology of Ductal Carcinoma in Situ Classification Based on Biologic Potential

  2006cites this paper
• Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast

  2005cites this paper
• 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.

  2005cites this paper
• Estrogen-Responsive Finger Protein as a New Potential Biomarker for Breast Cancer

  2005cites this paper
• The role of epigenetic inactivation of 14-3-3σ in human cancer

  2005cites this paper
• The role of epigenetic inactivation of 14-3-3sigma in human cancer.

  2005cites this paper
• Promotion of importin α–mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3

  2005cites this paper
• Increasing 14‐3‐3 sigma expression with declining estrogen receptor α and estrogen‐responsive finger protein expression defines malignant progression of endometrial carcinoma

  2005cites this paper